MXPA02003976A - Formulaciones de liberacion continua para el tratamiento de desordenes mediados por cns. - Google Patents

Formulaciones de liberacion continua para el tratamiento de desordenes mediados por cns.

Info

Publication number: MXPA02003976A
Authority: MX; Mexico
Prior art keywords: sustained; release formulations; mediated disorders; treating cns; cns
Prior art date: 1999-10-19

Application number

MXPA02003976A

Other languages

English (en)

Inventor

Lian G Rajewski

Original Assignee

Nps Pharma Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-10-19

Filing date

2000-10-19

Publication date

2003-09-25

2000-10-19 Application filed by Nps Pharma Inc filed Critical Nps Pharma Inc

2003-09-25 Publication of MXPA02003976A publication Critical patent/MXPA02003976A/es

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/18—Sulfonamides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/255—Esters, e.g. nitroglycerine, selenocyanates of sulfoxy acids or sulfur analogues thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
- A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Epidemiology (AREA)
Addiction (AREA)
Psychiatry (AREA)
Pain & Pain Management (AREA)
Reproductive Health (AREA)
Emergency Medicine (AREA)
Anesthesiology (AREA)
Gynecology & Obstetrics (AREA)
Pregnancy & Childbirth (AREA)
Endocrinology (AREA)
Dermatology (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicinal Preparation (AREA)

MXPA02003976A 1999-10-19 2000-10-19 Formulaciones de liberacion continua para el tratamiento de desordenes mediados por cns. MXPA02003976A (es)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US16021099P	1999-10-19	1999-10-19
PCT/US2000/041267 WO2001028516A2 (en)	1999-10-19	2000-10-19	Sustained-release formulations for treating cns-mediated disorders

Publications (1)

Publication Number	Publication Date
MXPA02003976A true MXPA02003976A (es)	2003-09-25

Family

ID=22575965

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
MXPA02003976A MXPA02003976A (es)	1999-10-19	2000-10-19	Formulaciones de liberacion continua para el tratamiento de desordenes mediados por cns.

Country Status (8)

Country	Link
EP (1)	EP1225888A2 (es)
JP (1)	JP2003512311A (es)
CN (1)	CN1409630A (es)
AU (1)	AU780505B2 (es)
CA (1)	CA2387819A1 (es)
MX (1)	MXPA02003976A (es)
TW (1)	TWI252761B (es)
WO (1)	WO2001028516A2 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6589994B1 (en)	1996-08-30	2003-07-08	Nps Pharmaceuticals, Inc.	Treating a variety of pathological conditions, including spasticity and convulsions, by effecting a modulation of CNS activity with isovaleramide, isovaleric acid, or a related compound
PA8578501A1 (es)	2002-07-25	2005-02-04	Pharmacia Corp	Forma de dosificacion una vez al dia de pramipexol
WO2006012603A2 (en) *	2004-07-22	2006-02-02	Nps Pharmaceuticals, Inc.	Analogs of isovaleramide, a pharmaceutical composition including the same, and a method of treating central nervous system conditions or diseases
DE602005024570D1 (de) *	2004-08-13	2010-12-16	Boehringer Ingelheim Pharma	Tablettenformulierung mit verlängerter freisetzung mit pramipexol oder einem pharmazeutisch zulässigen salz davon, herstellungsverfahren und verwendung dafür
SG164375A1 (en)	2004-08-13	2010-09-29	Boehringer Ingelheim Int	Extended release pellet formulation containing pramipexole or a pharmaceutically acceptable salt thereof, method for manufacturing the same and use thereof
US20070134315A1 (en) *	2005-12-08	2007-06-14	Viera Michael L	Orally administrable extended release pellet and tablet formulations of a highly water soluble compound

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2264577A1 (en) *	1996-08-30	1998-03-05	Nps Pharmaceuticals, Inc.	Treatment of spasticity, convulsions by isovaleric acid derivatives cns depressants

2000
- 2000-10-19 MX MXPA02003976A patent/MXPA02003976A/es active IP Right Grant
- 2000-10-19 CA CA002387819A patent/CA2387819A1/en not_active Abandoned
- 2000-10-19 EP EP00982701A patent/EP1225888A2/en not_active Withdrawn
- 2000-10-19 WO PCT/US2000/041267 patent/WO2001028516A2/en not_active Ceased
- 2000-10-19 AU AU19695/01A patent/AU780505B2/en not_active Ceased
- 2000-10-19 CN CN00817059A patent/CN1409630A/zh active Pending
- 2000-10-19 JP JP2001531111A patent/JP2003512311A/ja active Pending
2001
- 2001-04-11 TW TW090108635A patent/TWI252761B/zh not_active IP Right Cessation

Also Published As

Publication number	Publication date
CN1409630A (zh)	2003-04-09
EP1225888A2 (en)	2002-07-31
WO2001028516A2 (en)	2001-04-26
TWI252761B (en)	2006-04-11
CA2387819A1 (en)	2001-04-26
JP2003512311A (ja)	2003-04-02
WO2001028516A3 (en)	2002-02-21
AU780505B2 (en)	2005-03-24
AU1969501A (en)	2001-04-30

Publication	Publication Date	Title
ZA200110077B (en)	2003-03-06	Implanter apparatus.
ZA200109073B (en)	2003-01-29	Compositions for treatment of disorders of the oesophagus.
ZA200000733B (en)	2000-09-08	Process for fractionating dibutene.
HUP0101627A3 (en)	2003-02-28	Pharmaceutical compositions for treating neuropsychiatric disorders
AU3263901A (en)	2001-06-25	Methods for treating pervasive development disorders
MXPA02001088A (es)	2003-09-22	2-pirazolin-5-onas..
ZA200203252B (en)	2003-10-24	Process for preparing 4"-substituted-9-deoxo-9A-AZA-9A-homoerythromycina derivatives.
GB0030757D0 (en)	2001-01-31	Equi-pressure geosteering
ZA200006947B (en)	2002-05-27	Method for making 4-carboxyamino-2-substituted-1,2,3,4-tetrahydroquinoline.
GC0000155A (en)	2005-06-29	6-Hydroxy-indazole derivatives for treating glaucoma.
ZA200000857B (en)	2001-05-31	Pharmaceutical composition.
MXPA03006607A (es)	2003-09-22	Metodo combinado para tratar trastornos dependientes de hormonas.
ZA200202826B (en)	2003-09-23	Hydrodesulfurization process.
MXPA02003976A (es)	2003-09-25	Formulaciones de liberacion continua para el tratamiento de desordenes mediados por cns.
AU1603401A (en)	2001-10-03	Pyranoindoles for treating glaucoma
MXPA03001472A (es)	2003-06-06	Compuestos para el tratamiento de trastornos adictivos.
ZA200110539B (en)	2003-03-24	Oxazinocarbazoles for the treatment of CNS diseases.
MXPA01013023A (es)	2003-08-01	Agentes terapeuticos.
GB9912323D0 (en)	1999-07-28	Height adjuster system
IL154202A0 (en)	2003-07-31	Pharmaceutical compositions for treating anorectal disorders
ZA200107740B (en)	2003-02-26	Adjusting device.
GB2353794B (en)	2003-05-28	Deadplate assembly for I.S. machine
HU9902296D0 (en)	1999-10-28	Pharmaceutical composition for treating caltification
ZA991786B (en)	1999-09-06	Therapeutic treatment for asthma.
EP1142585A4 (en)	2005-08-03	DRUGS AGAINST CORNEAL DISORDERS

Legal Events

Date	Code	Title	Description
2007-08-20	FG	Grant or registration